Axsome Therapeutics (AXSM) Peer Comparison

$220.75

$9.64 (4.56%)

As on 11-Sep-2026 16:00EDT

Market cap

$10,826 Mln

Revenue (TTM)

$777 Mln

P/E Ratio

--

P/B Ratio

131

Div. Yield

0 %

Edit

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Market cap ($ Mln)	10,826	14,631	11,421	12,066	9,754
Revenue ($ Mln)	777	692	5,020	831	332,834
Net Profit ($ Mln)	-191.64	-696.24	-199.00	54.90	33,166.55
Net Margin (%)	-24.68	-100.64	-3.96	6.61	9.96
RoE (%)	-223.36	--	-3.03	8.11	8.88
Price to Earnings	--	--	--	248.04	28.56
Price-To-Book	131.04	123.68	1.79	17.29	2.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Operating Revenue	776.57	691.84	5,020.00	830.81	332,834.17
Cost of Revenue	52.53	47.45	2,380.00	14.09	165,910.29
Gross Profit	591.02	473.81	2,050.00	748.43	190,428.00
Operating Expenses	912.58	1,187.86	2,178.00	810.32	131,728.10
Operating Profit (EBIT)	-188.54	-543.47	462.00	6.41	35,195.77
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-191.09	-706.17	-166.00	26.37	41,359.76
Provision for Tax	0.56	-7.73	33.00	-35.26	8,582.66
Profit after Tax (Net Income)	-191.64	-696.24	-199.00	54.90	33,166.55
Minority Interest	0.00	10.15	0.00	0.00	389.00
Consolidated Profit	0.00	0.00	0.00	0.00	25,570.00

Liabilities ($ Mln)

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Shareholder's Funds	83.30	-2,515.22	6,588.00	705.78	383,428.00
Minority Interest	0.00	10.15	0.00	0.00	389.00
Non-Current Liabilities	217.70	2,832.54	5,121.00	29.12	31,229.00
Current Liabilities	460.45	890.65	1,852.00	153.80	157,341.00
Total Liabilities	689.81	936.03	13,358.00	836.65	492,989.00

Assets ($ Mln)

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Non-Current Assets	104.88	124.16	9,764.00	449.03	275,974.00
Current Assets	656.57	1,093.14	3,797.00	439.68	299,331.00
Total Assets	689.81	936.03	13,358.00	836.65	492,989.00
Total Debt*	219.21	2,493.78	3,918.00	9.42	71,952.00
Net Current Assets	196.12	202.49	1,945.00	285.87	141,990.00

Cashflow ($ Mln)

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Cash From Operating Activities	-93.41	-445.91	560.00	142.00	46,428.00
Cash Flow from Investing Activities	-0.48	-24.49	-279.00	69.76	-58,077.00
Cash from Financing Activities	101.47	359.29	-275.00	-220.37	18,911.00
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
ROCE (%)	-63.21	-159.44	-2.21	14.87	16.61
ROE (%)	-223.36	41.15	-3.03	8.11	8.88
ROA (%)	-17.39	-41.39	-1.30	5.52	4.76
EBIT Margin (%)	-17.57	-89.09	1.61	3.17	11.08
Net Margin (%)	-24.68	-100.64	-3.96	6.61	9.96
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Revenue Growth (%)	56.87	193.38	11.95	16.02	-0.43
EBIT Growth (%)	42.45	5.05	-90.61	-79.11	-53.96
Net Profit Growth (%)	22.38	10.33	-145.85	-58.66	-41.61
EPS Growth (%)	25.75	12.58	-146.42	-62.44	-41.56
Book Value Growth (%)	9.44	-36.90	-3.87	12.98	9.58

Valuation Ratios

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Price / Earnings	-50.48	-20.69	-48.47	41.86	0.19
Price / Book Value	104.73	-7.27	1.79	6.44	2.44
Dividend Yield (%)	--	--	0.00	--	0.71
EV/EBITDA	-54.53	-25.60	19.24	55.67	-0.01
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Debt to Equity	1.42	-0.77	0.58	0.00	0.00
Short term debt to equity ratio	0.85	-0.22	0.01	0.00	0.16
Current Ratio	1.43	1.23	2.05	2.86	1.90
Quick Ratio	1.34	1.17	1.10	2.77	1.39
Interest Coverage	-37.09	-6.86	0.36	--	10.86

Operating Efficiency Ratios

	Axsome Therapeutics (AXSM)	BridgeBio Pharma (BBIO)	Elanco Animal Health (ELAN)	Corcept Therapeutics (CORT)	Dr. Reddy's Laboratories - ADR
Debtors to sales (%)	35.73	36.78	22.95	9.26	37.38
Asset Turnover	0.70	0.41	0.33	0.84	0.48
Receivable days	104.82	52.44	70.73	28.27	115.08
Inventory Days	167.98	172.81	226.89	355.76	181.99
Payable days	529.03	296.14	45.50	785.55	56.23
Cash Conversion Cycle	-256.23	-70.89	252.12	-401.52	240.84

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly